Rivastigmine Tartrate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
46708-063 -
Package NDC
46708-063-10 -
Package NDC
46708-063-30 -
Package NDC
46708-063-60 -
Package NDC
46708-063-71 -
Package NDC
46708-063-91 -
Application number
ANDA091689 -
SPL ID
1ff4407e-25ad-4fa7-95dd-859e6589d5d1 -
SPL set ID
33e6a772-382d-45f5-9d45-966c07759367 -
UNII
9IY2357JPE -
RxCUI
312835 -
RxCUI
312836 -
RxCUI
314214 -
RxCUI
314215
What the source publishes
- Labeler
- Alembic Pharmaceuticals Limited
- Active ingredients
- Rivastigmine Tartrate
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Rivastigmine Tartrate",
"splId": "1ff4407e-25ad-4fa7-95dd-859e6589d5d1",
"labels": [
{
"setId": "33e6a772-382d-45f5-9d45-966c07759367",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33e6a772-382d-45f5-9d45-966c07759367",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33e6a772-382d-45f5-9d45-966c07759367"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (46708-063-10) / 10 CAPSULE in 1 BLISTER PACK (46708-063-11)",
"package_ndc": "46708-063-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20120613"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (46708-063-30)",
"package_ndc": "46708-063-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20120613"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (46708-063-60)",
"package_ndc": "46708-063-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20120613"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (46708-063-71)",
"package_ndc": "46708-063-71",
"identifierStatus": "well-formed",
"marketing_start_date": "20120613"
},
{
"sample": false,
"description": "1000 CAPSULE in 1 BOTTLE (46708-063-91)",
"package_ndc": "46708-063-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20120613"
}
],
"productId": "46708-063_1ff4407e-25ad-4fa7-95dd-859e6589d5d1",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "46708-063",
"deaSchedule": null,
"genericName": "Rivastigmine Tartrate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIVASTIGMINE TARTRATE",
"strength": "1.5 mg/1"
}
],
"applicationNumber": "ANDA091689",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120613",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0346708063306",
"0346708064303",
"0346708065300",
"0346708066307"
],
"unii": [
"9IY2357JPE"
],
"rxcui": [
"312835",
"312836",
"314214",
"314215"
],
"spl_set_id": [
"33e6a772-382d-45f5-9d45-966c07759367"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:46708-063_1ff4407e-25ad-4fa7-95dd-859e6589d5d1"